These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 10737693)

  • 1. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function.
    Carmelli D; DeCarli C; Swan GE; Kelly-Hayes M; Wolf PA; Reed T; Guralnik JM
    J Gerontol A Biol Sci Med Sci; 2000 Feb; 55(2):M103-9. PubMed ID: 10737693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
    Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
    Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
    Qiu C; Winblad B; Fratiglioni L
    Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
    Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ
    Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.
    Dik MG; Deeg DJ; Bouter LM; Corder EH; Kok A; Jonker C
    Stroke; 2000 Oct; 31(10):2431-6. PubMed ID: 11022076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins.
    Carmelli D; Swan GE; Reed T; Miller B; Wolf PA; Jarvik GP; Schellenberg GD
    Neurology; 1998 Jun; 50(6):1580-5. PubMed ID: 9633697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients.
    Wahlund LO; Julin P; Lannfelt L; Lindqvist J; Svensson L
    Dement Geriatr Cogn Disord; 1999; 10(4):262-8. PubMed ID: 10364643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
    Batterham PJ; Bunce D; Cherbuin N; Christensen H
    Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study.
    Winnock M; Letenneur L; Jacqmin-Gadda H; Dallongeville J; Amouyel P; Dartigues JF
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):794-7. PubMed ID: 12023428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
    Ballard CG; Morris CM; Rao H; O'Brien JT; Barber R; Stephens S; Rowan E; Gibson A; Kalaria RN; Kenny RA
    Neurology; 2004 Oct; 63(8):1399-402. PubMed ID: 15505155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of apolipoprotein E epsilon4 in the relationships of smoking and drinking to cognitive function.
    Carmelli D; Swan GE; Reed T; Schellenberg GD; Christian JC
    Neuroepidemiology; 1999; 18(3):125-33. PubMed ID: 10202267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
    Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
    Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.
    Jonker C; Schmand B; Lindeboom J; Havekes LM; Launer LJ
    Arch Neurol; 1998 Aug; 55(8):1065-9. PubMed ID: 9708956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study.
    DeCarli C; Reed T; Miller BL; Wolf PA; Swan GE; Carmelli D
    Stroke; 1999 Aug; 30(8):1548-53. PubMed ID: 10436099
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.
    Mayeux R; Small SA; Tang M; Tycko B; Stern Y
    Neurobiol Aging; 2001; 22(4):683-9. PubMed ID: 11445269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.
    Lopez OL; Jagust WJ; Dulberg C; Becker JT; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Jones B; Kawas C; Carlson M; Kuller LH
    Arch Neurol; 2003 Oct; 60(10):1394-9. PubMed ID: 14568809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.